These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 29485508)

  • 1. International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients.
    Charlton M; Levitsky J; Aqel B; OʼGrady J; Hemibach J; Rinella M; Fung J; Ghabril M; Thomason R; Burra P; Little EC; Berenguer M; Shaked A; Trotter J; Roberts J; Rodriguez-Davalos M; Rela M; Pomfret E; Heyrend C; Gallegos-Orozco J; Saliba F
    Transplantation; 2018 May; 102(5):727-743. PubMed ID: 29485508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppression in pediatric liver transplant recipients: Unique aspects.
    Miloh T; Barton A; Wheeler J; Pham Y; Hewitt W; Keegan T; Sanchez C; Bulut P; Goss J
    Liver Transpl; 2017 Feb; 23(2):244-256. PubMed ID: 27874250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppression Practices in Liver Transplantation: A Survey of North American Centers.
    Hussaini T; Turgeon RD; Partovi N; Erb SR; Scudamore CH; Yoshida EM
    Exp Clin Transplant; 2018 Oct; 16(5):550-553. PubMed ID: 28847263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [V Consensus Meeting of the Spanish Society for Liver Transplant on high-risk recipients, immunosupression scenarios and management of hepatocarcinoma on the transplant waiting list].
    Pardo F; Pons JA; Briceño J;
    Gastroenterol Hepatol; 2015 Dec; 38(10):600-18. PubMed ID: 26404045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Recipients.
    Terrault NA; Berenguer M; Strasser SI; Gadano A; Lilly L; Samuel D; Kwo PY; Agarwal K; Curry MP; Fagiuoli S; Fung JYY; Gane E; Brown KA; Burra P; Charlton M; Pessoa MG; McCaughan GW
    Transplantation; 2017 May; 101(5):956-967. PubMed ID: 28437388
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunosuppression minimization is safe and associated with good long-term success in pediatric recipients of liver transplant.
    Chapin CA; Whitehead B; Shakhin V; Taylor SA; Kriegermeier A; Mohammad S; Alonso EM
    Liver Transpl; 2024 Jul; 30(7):707-716. PubMed ID: 37934051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppression with budesonide for liver transplant recipients with severe infections.
    Bhat M; Ghali P; Wong P; Marcus V; Michel R; Cantarovich M; Metrakos P; Deschenes M
    Liver Transpl; 2012 Feb; 18(2):262-3. PubMed ID: 22006869
    [No Abstract]   [Full Text] [Related]  

  • 8. Durable Clinical and Immunologic Advantage of Living Donor Liver Transplantation in Children.
    Przybyszewski EM; Verna EC; Lobritto SJ; Martinez M; Vittorio JM; Fox AN; Samstein B; Kato T; Griesemer AD; Emond JC
    Transplantation; 2018 Jun; 102(6):953-960. PubMed ID: 29369249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Belatacept in Solid Organ Transplant: Review of Current Literature Across Transplant Types.
    Perez CP; Patel N; Mardis CR; Meadows HB; Taber DJ; Pilch NA
    Transplantation; 2018 Sep; 102(9):1440-1452. PubMed ID: 29787522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretransplant Psychosocial Risk Factors May Not Predict Late Nonadherence and Graft Rejection in Adult Liver Transplant Recipients.
    Lieber SR; Helcer J; Leven E; Knight CS; Wlodarkiewicz C; Shenoy A; Shemesh E; Florman SS; Schiano TD; Annunziato RA
    Exp Clin Transplant; 2018 Oct; 16(5):533-540. PubMed ID: 28969524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus infection in living donor liver transplant recipients significantly impacts the early post-transplant outcome: A single center experience.
    Yadav SK; Saigal S; Choudhary NS; Saha S; Sah JK; Saraf N; Kumar N; Goja S; Rastogi A; Bhangui P; Soin AS
    Transpl Infect Dis; 2018 Aug; 20(4):e12905. PubMed ID: 29668120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Enrichment and Restitution of the Peripheral Blood Treg Pool Is Associated With Rejection-Free Stable Immunosuppression After Liver Transplantation.
    Haarer J; Riquelme P; Hoffmann P; Schnitzbauer A; Schlitt HJ; Sawitzki B; Geissler EK; Hutchinson JA
    Transplantation; 2016 Jul; 100(7):e39-40. PubMed ID: 27326814
    [No Abstract]   [Full Text] [Related]  

  • 13. Trends of Immunosuppression and Outcomes Following Liver Transplantation: An Analysis of the United Network for Organ Sharing Registry.
    Cheng EY; Everly MJ
    Clin Transpl; 2014; ():13-26. PubMed ID: 26281123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group.
    Neuberger JM; Bechstein WO; Kuypers DR; Burra P; Citterio F; De Geest S; Duvoux C; Jardine AG; Kamar N; Krämer BK; Metselaar HJ; Nevens F; Pirenne J; Rodríguez-Perálvarez ML; Samuel D; Schneeberger S; Serón D; Trunečka P; Tisone G; van Gelder T
    Transplantation; 2017 Apr; 101(4S Suppl 2):S1-S56. PubMed ID: 28328734
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Manzia TM; Angelico R; Gazia C; Lenci I; Milana M; Ademoyero OT; Pedini D; Toti L; Spada M; Tisone G; Baiocchi L
    World J Gastroenterol; 2019 Sep; 25(35):5356-5375. PubMed ID: 31558879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Everolimus in Liver Transplantation: Recommendations From a Working Group.
    De Simone P; Fagiuoli S; Cescon M; De Carlis L; Tisone G; Volpes R; Cillo U;
    Transplantation; 2017 Feb; 101(2):239-251. PubMed ID: 27495768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver transplantation for viral hepatitis in 2015.
    Ferrarese A; Zanetto A; Gambato M; Bortoluzzi I; Nadal E; Germani G; Senzolo M; Burra P; Russo FP
    World J Gastroenterol; 2016 Jan; 22(4):1570-81. PubMed ID: 26819523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of early corticosteroid withdrawal on graft survival in liver transplant recipients.
    Meadows HB; Taber DJ; Pilch NA; Tischer SM; Baliga PK; Chavin KD
    Transplant Proc; 2012 Jun; 44(5):1323-8. PubMed ID: 22664009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
    Charlton M; Seaberg E
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S107-14. PubMed ID: 10431024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Associated With Recurrence of Underlying Diseases Among Liver Transplant Recipients: A Single-Center Study.
    Shamsaeefar A; Shojaei S; Nikoupour H; Mashhadiagha A; Moosavi SA; Sayadi M; Gholami S; Motazedian N; Geramizadeh B; Malekhosseini SA
    Exp Clin Transplant; 2024 May; 22(5):366-372. PubMed ID: 38970279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.